-
Solid IO
Created in 2025
-
-
Up & running (A)
Existing signals show a regular activity -
Social networks
2,177 -
Activities
-
Technologies
-
Entity types
-
Location
Haartmaninkatu 4 building 14, 00290 Helsinki, Finland
Helsinki
Finland
-
Employees
Scale: 2-10
Estimated: 13
-
Engaged catalyst
8
0 0 -
Added in Motherbase
1 year, 5 months ago
-
Value proposition
Real biology in. High-impact insights out. Unlocking immuno-oncology.
At Solid IO, we are transforming oncology and immunotherapy with next-generation organ-on-chip technology powered by advanced bioengineering and AI. Our patient-specific tumor models provide real-time, biologically relevant insights that help oncologists, researchers, and pharmaceutical innovators make precise, informed treatment decisions.
By replicating the tumor microenvironment and combining it with computational intelligence, our platform eliminates uncertainty, accelerates drug development, optimizes clinical trials, and expands access to advanced cancer therapies.
With Solid IO, the next era of precision oncology begins now.
➡️ Advancing immuno-oncology research
➡️ Bridging science, bioengineering & clinical application
➡️ Optimizing drug development & patient outcomes with AI-supported insights
WHY SOLID IO?
✅ Real-time patient-specific insights — Predict treatment responses before and during therapy.
✅ Faster, more efficient drug development — Reduce trial timelines and optimize biomarker validation.
✅ Transforming immuno-oncology — Unlock next-gen personalized immunotherapies.
✅ Powered by advanced bioengineering & AI — Turning biological complexity into actionable decisions.
✅ Scalable, global impact — Making precision oncology more accessible & clinically relevant.
Bringing precision to where it matters most — real-world patient care.
WHO WE WORK WITH
• Cancer Clinics & Research Centers — Advance breakthrough trials & personalized treatment pathways.
• Pharmaceutical & Biotech Companies — Accelerate drug R&D, patient stratification, and regulatory approvals.
• Investors & Partners — Drive global expansion and impact in precision medicine.
We are seeking visionary partners to push the boundaries of precision oncology.
Let’s collaborate to redefine cancer care.
Visit our website: www.solid-io.com
Partner with us: noora.hujala@solid-io.com
Based in Helsinki, Finland | Collaborating Globally
-
Solid IO | Ending Guesswork in Cancer Care with Organ-on-Chip Technology
Solid IO is transforming precision oncology with organ-on-chip technology, delivering real-time, patient-specific insights to improve cancer treatment decisions.
https://www.solid-io.com/
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
EIT - European Institute of Innovation and Technology
European Union, Government Administration (Auto) |
EIT - European Institute of Innovation and Technology
European Union, Government Administration (Auto) |
Other
31 May 2026 |
|
|
Cap Digital
Public business cluster, French Cluster, IT Services and IT Consulting (Auto) |
Cap Digital
Public business cluster, French Cluster, IT Services and IT Consulting (Auto) |
Other
31 May 2026 |
|
|
Bpifrance
Bank, Banking (Auto) |
Bpifrance
Bank, Banking (Auto) |
Other
28 Feb 2026 |
|
|
EU-Startups
Media, Technology, Information and Media (Auto) |
EU-Startups
Media, Technology, Information and Media (Auto) |
Other
28 Jan 2026 |
|
|
UK Research and Innovation
Public business cluster, Research Services (Auto) |
UK Research and Innovation
Public business cluster, Research Services (Auto) |
Other
31 Oct 2025 |
|
|
Merck Group
Pharmaceutical, Biotechnology, Pharmaceutical Manufacturing (Auto) |
Merck Group
Pharmaceutical, Biotechnology, Pharmaceutical Manufacturing (Auto) |
Other
30 Sep 2025 |
|
|
Bayer
Pharmaceutical, Chemistry, Chemical Manufacturing (Auto) |
Bayer
Pharmaceutical, Chemistry, Chemical Manufacturing (Auto) |
Other
28 May 2026 |
|
|
Slush
Non-profit Organizations (Auto) |
Slush
Non-profit Organizations (Auto) |
Other
31 Oct 2025 |
|
|